Treatment approach in addressing Demodex mites on lids

Article

Milton Hom, OD, FAAO, discussed diagnosis and treatment of the mite Demodex at the American Academy of Optometry’s annual meeting in Seattle.

 

Seattle-Milton Hom, OD, FAAO, discussed diagnosis and treatment of the mite Demodex at the American Academy of Optometry’s annual meeting in Seattle.

Demodex are found in 100% of patients 70+ years of age, and mite density rises in the sixth decade of life.

The clinical sequence includes:

• Clinical history, including blepharitis, dry eye, or ocular allergy;

• Slit-lamp examination, looking specifically for cylindrical dandruff;

• Microscopic confirmation of Demodex, including counting of eggs, larvae, and adults.

Patients with an overinfestation of Demodex exhibit symptoms of itch, burning, foreign body sensation, crusting, redness, and blurry vision. Some 85% of patients with Demodex also have meibomian gland dysfunction.

Cylindrical dandruff is a hallmark of Demodex. About 12.9 mites per patients were found with signs of cylindrical dandruff, in contrast to 0.35 mites per patient without.

Rosacea patients have a 7 to 8 times higher incidence of Demodex. “If you see rosacea and no Demodex, you’re missing it,” says Dr. Hom.

In-office treatments include lid scrubs, tea tree oil, and use of a bleph brush. Patients need to return for several treatments over the course of several weeks and add a home regimen. Suggest use of tea tree oil shampoo and soap to patients with an infestation of Demodex. Remember that everyone has some Demodex; we just try to control the numbers when they get out of hand.

Tips:

• Tea tree oil pads are sometimes dry on one side, so squeeze the pad so both sides are wet.

• Don’t forget children…kids can have large Demodex populations as well as adults.

• Mites are frequently mistaken for allergy.

• When epilating lashes, look for cylindrical dandruff at the base of the lash, and look for “sick” lashes (short, discolored, misdirected).

Dr. Hom’s banned list for Demodex control:

• Steroids;

• Emulsion drops;

• Restasis (cyclosporine, Allergan);

• Prostaglandins (these stimulate mite counts);

• Latisse (bimatoprost, Allergan);

• Antibiotics (useless in controlling mite population).

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.